Evidence suggests that the Janus kinase 2/signal transducers and activators of transcription 5 (JAK2/STAT5) pathway plays a critical role in CML leukemogenesis [3, 4]. This evidence concerns the gene JAK2 and chronic myelogenous leukemia, BCR-ABL1 positive.